期刊文献+

GRACE与TIMI评分对ST段抬高型心肌梗死患者预后评估的价值 被引量:10

Predictive value of GRACE score and TIMI score in the patients of ST-segment elevation myocardial infarction
原文传递
导出
摘要 目的比较全球急性冠状动脉事件注册研究(Global Registry for Acute Coronary Events,GRACE)评分及心肌梗死溶栓治疗评分系统(The Thrombolysis in Myocardial Infarction,TIMI)评分对ST段抬高型心肌梗死(ST segment elevation myocardial infarction,STEMI)患者预后评估的临床价值。方法 280例因STEMI接受急诊经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗的患者的临床资料,分别计算GRACE及TIMI评分,根据评分结果分为低、中、高危组。随访患者发病后12个月主要心血管不良事件(major adverse cardiac events,MACE)发生情况,通过计算两种评分系统的受试者工作特征曲线(ROC曲线)的面积评估其预测价值,并比较两者预测价值的能力。结果不论是GRACE评分还是TIMI评分,危险分层越高,患者术后12个月MACE发生率越高(P<0.01),而且TIMI评分的高危组患者MACE的发生率显著高于GRACE评分的高危组患者(P<0.05)。TIMI评分和GRACE评分ROC曲线下面积无统计学差异。GRACE预测MACE的灵敏度为87%,特异度为58%,正确指数(Youden index)为0.45;TIMI灵敏度为54%,特异度为90%,正确指数为0.44,GRACE评分预测STEMI预后的灵敏度显著高于TIMI评分(87%vs.54%,P<0.01),而其特异度显著低于TIMI评分(58%vs.90%,P<0.01),两组正确指数的差异则无统计学意义(0.45 vs.0.44)。结论两种评分体系总体预测能力的差异无统计学意义。但GRACE评分灵敏度高,而TIMI评分特异度高。 AIM The study was performed to compare the predictive value between thrombolysis in myocardial infarction (TIMI) scores and global registry for acute coronary events (GRACE) scores in patients with ST-Elevation Myocardial Infarction (STEMI). METHODS 280 consecutive STEMI patients who had undergone percutaneous coronary intervention (PCI) were enrolled in the current study. According to the two scores system, the patients were divided into low risk, moderate risk, and high risk groups, respectively. All the patients were followed up for 12 months to learn the major adverse cardiac events (MACE) rate. The receiver operating characteristic (ROC) curve was depicted for the two score system to evaluate and to compare the predictive capability. RESULTS The patients with high risk group of GRACE and TIMI scores had higher incidence of MACE at 12 months (P〈0.01). Moreover, the high risk group of TIMI score had significantly higher incidence of MACE than that in high risk group of GRACE score (P〈0.05). However, there was no significant difference between the area under ROC of GRACE score and TIMI score. The GRACE score predicted MACE with the sensitivity of 87%, specificity of 58% and Youden index of 0.45. The TIMI score had the sensitivity of 54%, the specificity of 90%and the Youden index of 0.44. Compared with TIMI score, GRACE score had higher sensitivity (87% vs. 54%, P〈0.01) and lower specificity (58% vs. 90%, P〈0.01). There were no difference in the Youden index (0.45 vs. 0.44) between the two groups. CONCLUSION The two risk scores show similar predictive capacity of MACE for the overall patient cohort at 12 months. GRACE score has a high sensitivity, while TIMI score has a high specificity.
作者 陈诤 张新林 吴韩 谢峻 戴庆 魏钟海 CHEN Zheng;ZHANG Xin-lin;WU Hart;XIE Jun;DAI Qing;WEI Zhong-hai(Department of Cardiology, Nanjing Drum Tower Hospital Affiliated the Medical School of Nanjing University, Nanjing 210008, Jiangsu, China)
出处 《心脏杂志》 CAS 2018年第4期434-438,共5页 Chinese Heart Journal
关键词 ST段抬高型心肌梗死 全球急性冠状动脉事件注册研究评分 心肌梗死溶栓治疗评分 ST-segment elevation myocardial infarction Global Registry for Acute Coronary Events score Thrombolysis in Myocardial Infarction score
  • 相关文献

参考文献2

二级参考文献14

  • 1The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J, 2000, 21:1502-1513.
  • 2Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction :2008-2009 revision. Int J Epidemiol, 2011, 40:139-146.
  • 3White HD. Pathobiology of troponin elevations. J Am Coll Cardiol, 2011,57:2406-2408.
  • 4Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers Cardiac Damage Laboratory Medicine Practice Guidelines : Analytical issues for biochemical markers of acute coronary syndromes. Circulation, 2007, 115 : e352- e355.
  • 5Thygesen K, Mair J, Katus H, et al. Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J, 2010, 31:2197-2204.
  • 6Thygesen K, Mair K, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J, 2012, 33:2252-2257.
  • 7Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem, 2012, 58:54-61.
  • 8Jaffe AS, Apple FS, Morrow DA, et al. Being rational about (im) precision : a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem, 2010, 56:941-943.
  • 9White HD, Reynolds HR, Carvalho AC, et al. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction : Results from long- term follow-up of the Occluded Artery Trial (OAT) cohort. Am Heart J, 2012, 163:563-571.
  • 10Rosamond W, Chambless L, Heiss G, et al. Twenty-two year trends in incidence of myocardial infarction, CHD mortality, and case-fatality in four US communities, 1987 to 2008. Circulation, 2012,125:1848-1857.

共引文献189

同被引文献96

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部